Finance

Lists
Why is AVE down 11,11%?
Dive Deeper
AVE:ASX
Avecho Biotechnology Ltd
0,016 AUD
-11,11%
(-0,0020) 1D
9-окт., 16:10:30 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Open
0,02 AUD
High
0,02 AUD
Low
0,02 AUD
Mkt. cap
55,64 млн
Avg. vol.
2,82 млн
Volume
7,77 млн
52-wk high
0,03 AUD
52-wk low
0,00 AUD
EPS
-0,00 AUD
Shares outstanding
3,86 млд
No. of employees
15
Open
0,02 AUD
High
0,02 AUD
Low
0,02 AUD
Mkt. cap
55,64 млн
Avg. vol.
2,82 млн
Volume
7,77 млн
52-wk high
0,03 AUD
52-wk low
0,00 AUD
EPS
-0,00 AUD
Shares outstanding
3,86 млд
No. of employees
15
News stories
From web sources and news partners
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
338,85 миң
338,85 миң
29,80 миң
29,80 миң
Cost of goods sold
92,11 миң
92,11 миң
7,76 миң
7,76 миң
Cost of revenue
92,11 миң
92,11 миң
7,76 миң
7,76 миң
Research and development expenses
478,93 миң
478,93 миң
221,87 миң
221,87 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
441,76 миң
441,76 миң
737,40 миң
737,40 миң
Operating expense
920,69 миң
920,69 миң
959,27 миң
959,27 миң
Total operating expenses
1,01 млн
1,01 млн
967,03 миң
967,03 миң
Operating income
-673,96 миң
-673,96 миң
-937,23 миң
-937,23 миң
Other non operating income
-
-
-
-
EBT including unusual items
-870,33 миң
-870,33 миң
-961,82 миң
-961,82 миң
EBT excluding unusual items
-870,33 миң
-870,33 миң
-961,82 миң
-961,82 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-870,33 миң
-870,33 миң
-961,82 миң
-961,82 миң
Net profit margin
-256,85%
-256,85%
-3 227,46%
-3 227,46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-196,38 миң
-196,38 миң
-24,59 миң
-24,59 миң
Net interest expenses
-196,38 миң
-196,38 миң
-24,59 миң
-24,59 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-639,62 миң
-639,62 миң
-909,80 миң
-909,80 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору